Clinical Trial Update: Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of GSK2330672 in Japanese healthy male volunteers for cholestasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis

Drugs mentioned

• GSK2330672

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cholestasis | Phase 1 | Status: COMPLETED